Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
सिद्धार्थ Profile picture
@das_seed
Sep 25, 2020 • 22 tweets • 24 min read • Read on X
Scrolly
How can medical insurance companies NOT trick their customers!

Guidelines on handling of claims reported under Corona Virus: irdai.gov.in/ADMINCMS/cms/w…

(Images from thread below by @AnooBhu)

ImageImageImage
Ashraya Hospital, Chikmagalur, Karnataka

Bill splitting:

Doctor's visit charges alone is ~₹2 lakhs.

Separate hefty charges for COVID ICU, oxygen, NIV, etc.

Hospital admit: 24.08.20, discharge: 11.09.20

@malini_aisola @RemaNagarajan @inayat_s_kakar

Image
Is @MaxHealthcare charging ₹ 8 lakhs when earlier estimated cost to the patient was ₹ 3.5 lakhs? What sort of inflation is this?

@malini_aisola @RemaNagarajan

Image
❗️Action against 27 TN pvt hospitals for overcharging: 1 hospital pulled up for discharging a patient at midnight for being unable to pay bill, some others had to make settlements of up to Rs 2 lakh after charging excess fees.



newindianexpress.com/states/tamil-n… Image
#COVID19 Pune: Measures to curtail overcharging ineffective.

The audit teams would only check bills of patients who've been charged more than ₹1.5 lakh, leaving majority of patients out of its purview. via @varshasuman

cc @malini_aisola @RemaNagarajan

thewire.in/health/covid-1…
Thread by @malini_aisola about billing of PPE & prices paid by patients for COVID treatment.

ImageImageImage
Looks like weird refusal of mediclaim from @StarHealthIns.

Total bill is ₹ 6.41 lakh. Can one not use multiple insurance policies/claims to cover the bill?

@malini_aisola @RemaNagarajan @ramavenu @suchetadalal @MoneylifeIndia

Image
@MaxHealthcare profiteering from COVID19 patients.

Also note that Tocilizumab is still mentioned when there's no +ve evidence and only -ve results from RCTs so far. Also, check how exaggerated other charges are on daily basis.

@malini_aisola

ImageImage
Moolchand Healthcare @Moolchand_Hosp w/ post-COVID19 packages. Doctor consultation also for "Ayurveda".

Where is line between evidence-based treatment & quackery? Are patients clarified on method of treatment & evidences behind?

@malini_aisola

Image
#MedicalHostage When patients or deceased are kept hostage by hospitals until bills are paid as per demand of hospital admins.

News story on issue covered by @SwetaDash93: thewire.in/health/private…

#HealthRacket

Image
Image
1. Referral to fraudulent firm for loans by @MaxHealthcare staff and later not helping customer solve the issue arising due to it.

2. Overcharging of ambulance fees.

Image
Ex-servicepersons are also troubled by some ECHS Empanelled Hospitals. Some ECHS hospitals refuse to provide required medical attention which has also led to deaths.

@malini_aisola @RemaNagarajan @sanjg2k1 @drharshvardhan @MoHFW_INDIA @adgpi @PMOIndia
ImageImage
Dhanwantri Nursing Home, MBD under Dr Ankit Verma took ₹137000 cash advance from patient. But doctor is refusing to give proper bill (w/ batch no.) for drugs on discharge. Patient's kin also concerned for genuineness of drugs prescribed/used. @ICMRDELHI
ImageImage
Outright overcharging patient (e.g., multiple ICU charges for same day) by @NarayanaHealth.

Tocilizumab to 85 yr old lady w/ moderately severe or severe COVID19 seems medical negligence. There's only -ve evidences so far, see thread 👇.

@drlokeshksharma
ImageImageImage
📢Cautionary notice for @Director_NABH accredited "allopathic" hospitals.

Some NABH accredited allopathic hospitals are employing AYUSH doctors for clinical duties @ ICU & other patient cares meant for MBBS RMOs & emergency doctors.

via @malini_aisola
Image
Patient age 62 yrs, admitted on 28 Oct '20 @HospitalsApollo, Belapur. For 40 days of COVID19 related treatment, bill of ₹ 22 lakhs bill on 8 Dec '20. Family was told that further 1 month needed for recovery as per hospital, w/ est cost of ₹ 50 lakhs.

Image
Star Hospital, Hyderabad charging COVID19 patient for over ₹ 1 lakh per day. Also possibility of polypharmacy (incl. plasma therapy). Medicines/consumable alone are over ₹4 lakhs.

Are state govts & central govt monitoring COVID19 treatment costs?
ImageImage
Details described by @RakeshMithai show thuggery of Medicare Hospital, Nagpur. It's plain loot & lack of empathy towards patients. They not only denied medical bill, but also claimed/bargained unnecessary amount for treatment patient didn't avail.
ImageImageImage
Farmers in Nashik being looted by some pvt hospitals: no billing, over charging, etc other than rude behavior towards patients & families. Also, Pvt hospitals seem to be taking benefit of lack of awareness about possible home care for mild COVID19.
ImageImageImageImage
CHL Hospital, Indore is overcharging for COVID19 treatment, & threat of no medicine if no payment.

8 days in hospital.

Consultancy: ₹26800
PPE kit: ₹9000
Oxygen: ₹24000
Room: ₹45400 (incl. of single day ICU)
....
Total: ~₹3.2 lakhs+ Service: ₹30000
ImageImageImage
Ashoka Medicover Hospital Nashik charged ₹ 7.4 lakh to @j_baviskar's father huge bill for COVID19 treatment (15 Feb 2021 to 1 March 2021).

(Price of Ulinafic Inj seem to be more than online sale price.)

(Did they inject 7 Remdesivir &1 Tocilizumab too?)
ImageImage

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with सिद्धार्थ

सिद्धार्थ Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @das_seed

सिद्धार्थ Profile picture
Jul 2, 2021
Phase 3 trial results for COVAXIN (a double-blind, randomised, placebo-controlled trial). Thread.

medrxiv.org/content/10.110… 2 July 2021.

1. Vaccine efficacy against

● Symptomatic COVID19+ve: 77.8% (95% CI: 65.2–86.4) w/ 130 cases (24 COVAXIN, 106 placebo) Image
● Severe symptomatic COVID-19+ve: 93·4% (57·1–99·8) w/ 16 cases (1 COVAXIN, 15 placebo)

● Symptomatic COVID19+ve in age 18–59 yrs: 79·4% (66–88·2) w/ 109 cases (19 COVAXIN, 90 placebo)

● Asymptomatic COVID19+ve: 63·6% (29🤔–82·4) w/ 47(?) cases (13 COVAXIN+33 placebo=46🤦) ImageImage
2. Vaccine efficacy against symptomatic COVID19+ve

● B.1.617.2 (Delta): 65·2% (33·1–83·0) w/ 50 cases (13 COVAXIN, 37 placebo)

● B.1.617.1 (Kappa): 90·1% (30·4–99·8) w/ 11 cases (1 COVAXIN, 10 placebo)

3. Total 79 variants (VOIs or VOCs) detected in 130 cases analyzed for Image
Read 21 tweets
सिद्धार्थ Profile picture
Jul 2, 2021
Based on recommendations from NTAGI, @MoHFW_INDIA on 2 July 2021 approved the vaccination of pregnant women against COVID-19.

Decision allows pregnant women to make an informed choice on taking COVID vaccination.

Decision communicated to the states/UTs.
pib.gov.in/PressReleasePa…
FAQ by @MoHFW_INDIA circulated among designated health practitioners before approval to allow COVID19 vaccination in pregnant women.

NTAGI had recommended studies to monitor safety of COVID19 vaccine in pregnant to be put in place immediately. Any update?
@MoHFW_INDIA says that pregnant woman opting for vaccination can get COVID19 vaccinated available in India any time during pregnancy.🤦‍♀️

(Not all vaccines have same safety profile. NTAGI had noted concerns along w/ recommendation to allow COVID19 vaccination for pregnant).
Read 6 tweets
सिद्धार्थ Profile picture
Jul 2, 2021
Should Indians be concerned about commercial COVAXIN deals by @BharatBiotech?

@ICMRDELHI & @BharatBiotech have MoU on COVAXIN and also share Intellectual Property rights.

ICMR gets 5% on net sales of COVAXIN as royalty from BBIL.

Partial COVAXIN trials & mfg support from
Indian govt.

Not to forget super-extraordinary regulatory authorization to COVAXIN w/o Phase 3 trial data that allowed BBIL to opened door for early sales of COVAXIN in India & some other nations.

During early days, COVAXIN consignments only had BBIL's logo but not of ICMR.
However, there're COVAXIN consignments featuring logos of both developers, ICMR & BBIL, from March.

Commercial supply of 2 lakh COVAXIN doses to Mauritius on 19 March had logos of ICMR & BBIL w/ sign of #VaccineMaitri by Indian govt.

Was ICMR logo because of int'l shipment? No.
Read 8 tweets
सिद्धार्थ Profile picture
Jul 1, 2021
What do we know about ZyCoV-D, a plasmid DNA vaccine candidate against symptomatic COVID19 by Zydus Cadila? Thread.

1. Results of pre-clinical studies on animals before July 2020 put in public domain in 2021:
biorxiv.org/content/10.110… 26 Jan 2021
biorxiv.org/content/10.110… 3 Feb 2021
2. Permission granted by DCGI on 2 Jun 2021 to initiate human trials adaptive Phases I & II.

Safety profile of 7 days after 1st dose of ZyCoV-D needed to be reviewed by DSMB & CDSCO before go ahead for Phase 2.

Some issues w/ these permissions are:
a) ZyCoV-D needs 3 doses for
completion (at day 0, day 28, day 56).

b) Vaccine candidate platform/tech is new for humans. 7 days for such a new vaccine candidate is too short period for monitoring. SAEs could occur based on dosages as well & some type of events may take longer to manifest.

c) Phase I trial
Read 26 tweets
सिद्धार्थ Profile picture
May 24, 2021
A short note on dosing regimen of COVISHIELD for complete vaccination.

We've 3 different set of trials:

1. UK/Brazil trials
This trial was open-label, w/ scandalous error in dosing regimen ("half-dose" error), had multiple major amendments in protocol when trial was undergoing Image
w/ minimum gap b/w 2 doses set to be 4 weeks.

COVISHIELD was initially supposed to be a single dose vaccine, but in middle of trial they realized that booster dose was required for higher efficacy compared to just single dose.

In the process, due to mfg/supply delay, intended Image
interval of 4 weeks was not achieved & got prolonged.

Attached are intended & extrapolated sub-group analysis that was carried out by PIs as part of protocol, w/ different dosing levels & intervals.

*extrapolated analyses were not part of protocol hypothesis but in response to ImageImage
Read 17 tweets
सिद्धार्थ Profile picture
Apr 11, 2021
A thread on recent updates (24 March- 9 April 2021) on Vaxzevria, a COVID19 vaccine mfg by AstraZeneca (called COVISHIELD if the same product is mfg by @SerumInstIndia).

1. Summary of productcharacteristics updated by @AstraZeneca after @EU_Commission's decision. Importantly, ImageImageImage
a) Thromobocytopenia is listed as common (≥1/100 to <1/10) adverse reaction

b) Thrombosis in combination w/ thrombocytopenia is listed as very rare (<1/10,000) adverse reaction

c) Currently available trial data do not allow an estimate of vaccine efficacy in 55+ yrs age group. Image
d) Asks healthcare professionals to be on alert for signs & symptoms of thromboembolism &/or thrombocytopenia. Instructs vaccinated people to seek immediate medical attention if they develop symptoms such as shortness of breath, chest pain, leg swelling, persistent abdominal pain ImageImage
Read 16 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

Send Email!

:(